Nexalin Technology has secured a US patent related to its non-invasive, frequency-based deep brain stimulation device, Gen-3 HALO Clarity system.
Awarded by the United States Patent and Trademark Office (USPTO), the patent is entitled “Transcranial Alternating Current Dynamic Frequency Stimulation Method for Anxiety, Depression and Insomnia (ADI)”.
It covers the method of use for the device, which is designed to treat anxiety, depression, and insomnia (ADI), from the comfort of patients’ homes.
